We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+676.44%
AUM
$468M
AUM Growth
+$40.6M
Cap. Flow
+$9.39M
Cap. Flow %
2%
Top 10 Hldgs %
39.99%
Holding
136
New
11
Increased
63
Reduced
36
Closed
7

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$7.51M
2
BABA icon
Alibaba
BABA
+$6.91M
3
TDOC icon
Teladoc Health
TDOC
+$3.8M
4
INTC icon
Intel
INTC
+$2.04M
5
CGC
Canopy Growth
CGC
+$1.08M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Consumer Discretionary 15.36%
3 Financials 12.54%
4 Communication Services 12.02%
5 Healthcare 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSV icon
26
Vanguard Short-Term Bond ETF
BSV
$45.7B
$5.37M 1.15%
64,933
+255
+0.4% +$21K
NVDA icon
27
NVIDIA
NVDA
$5.46T
$5.27M 1.13%
263,640
+400
+0.2% +$6.41K
ARKG icon
28
ARK Genomic Revolution ETF
ARKG
$1.78B
$5M 1.07%
54,044
+4,798
+10% +$408K
DKNG icon
29
DraftKings
DKNG
$12.6B
$4.8M 1.03%
92,107
+800
+0.9% +$42.2K
DXC icon
30
DXC Technology
DXC
$1.79B
$4.79M 1.02%
122,964
+46,740
+61% +$1.67M
ALLY icon
31
Ally Financial
ALLY
$13.6B
$4.75M 1.01%
95,200
+5,490
+6% +$282K
GM icon
32
General Motors
GM
$75.8B
$4.46M 0.95%
75,419
+4,512
+6% +$265K
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$131B
$4.32M 0.92%
21,442
+3,157
+17% +$660K
REGN icon
34
Regeneron Pharmaceuticals
REGN
$83B
$4.31M 0.92%
7,713
+244
+3% +$124K
BNDX icon
35
Vanguard Total International Bond ETF
BNDX
$83B
$4.1M 0.88%
71,777
-358
-0.5% -$20.4K
SCHD icon
36
Schwab US Dividend Equity ETF
SCHD
$108B
$3.92M 0.84%
155,643
+288
+0.2% +$7.27K
AGG icon
37
iShares Core US Aggregate Bond ETF
AGG
$138B
$3.88M 0.83%
33,653
+387
+1% +$44.3K
BMY icon
38
Bristol-Myers Squibb
BMY
$132B
$3.66M 0.78%
54,793
+460
+0.8% +$30K
IOO icon
39
iShares Global 100 ETF
IOO
$9.46B
$3.63M 0.78%
51,195
+9,370
+22% +$653K
PYPL icon
40
PayPal
PYPL
$51.8B
$3.58M 0.76%
12,277
+1,960
+19% +$518K
NVTA
41
DELISTED
Invitae Corporation
NVTA
$3.29M 0.7%
97,530
+6,870
+8% +$223K
FSLR icon
42
First Solar
FSLR
$24B
$3.24M 0.69%
35,800
-285
-0.8% -$22.6K
SCHP icon
43
Schwab US TIPS ETF
SCHP
$16.2B
$3.22M 0.69%
102,992
+18,864
+22% +$585K
NCLH icon
44
Norwegian Cruise Line
NCLH
$8.98B
$3.17M 0.68%
+107,895
New +$3.25M
TRMB icon
45
Trimble
TRMB
$13.4B
$3.06M 0.65%
37,415
+5,845
+19% +$465K
DAL icon
46
Delta Air Lines
DAL
$60B
$2.87M 0.61%
66,436
-1,289
-2% -$59.7K
BND icon
47
Vanguard Total Bond Market
BND
$162B
$2.82M 0.6%
32,868
-600
-2% -$51.2K
SPY icon
48
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$2.73M 0.58%
6,388
-105
-2% -$43.8K
VZ icon
49
Verizon
VZ
$200B
$2.7M 0.58%
48,258
+147
+0.3% +$8.44K
SCHE icon
50
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$2.6M 0.55%
78,960
+2,849
+4% +$92.4K

Similar funds

Fagan Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Fagan Associates held 136 positions worth $468M, up 9.5% from $428M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fagan Associates's Q2 2021 filing shows 11 new, 63 increased, 36 reduced and 7 closed positions. Its largest new stake was IBM: 46,878 shares worth $6.57M. The largest sale was AT&T, an estimated $7.51M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Fagan Associates's largest Q2 2021 buy was IBM: 46,878 shares worth $6.57M.
  • Fagan Associates added most to Bank of America in Q2 2021, an estimated $3.07M increase.
  • Fagan Associates's biggest Q2 2021 reduction was AT&T, cutting an estimated $7.51M.
  • Fagan Associates fully exited Teladoc Health in Q2 2021, selling an estimated $3.8M.
  • Fagan Associates's ten largest holdings make up 40% of its $468M portfolio in Q2 2021.
  • Fagan Associates opened 11 new positions and closed 7 in Q2 2021.
  • Fagan Associates's portfolio value rose 9.5% quarter-over-quarter to $468M.

Based on Fagan Associates's 13F filing for Q2 2021, filed 6 Aug 2021.